Third Pfizer COVID-19 vaccine dose ‘likely’ needed within year, CEO says
Fox News
Those who completed the two-dose regimen for Pfizer’s COVID-19 vaccine will likely need a third shot within 12 months, CEO Albert Bourla said.
"It is extremely important to suppress the pool of people that can be susceptible to the virus," Bourla told CNBC’s Bertha Coombs in a CVS Health Live event, "Race to Vaccinate." Pfizer recently announced updated results indicating its vaccine was highly effective up to six months after the second dose, with findings stemming from over 12,000 participants in a late-stage trial. Findings included a 91.3% vaccine efficacy against COVID-19, and over 95% efficacy against severe disease.More Related News